"ColdZyme® addresses the underlying cause of colds by preventing viruses from spreading and allows the body to recover faster."
Shorter illness duration:
ColdZyme reduced the duration of upper respiratory tract infections.
New study:
ColdZyme® reduces cold duration and symptoms
A new scientific article published in the The Journal of Physiology, confirms that ColdZyme not only alleviates cold symptoms but can also reduce the number of sick days. The article is a collaboration between the University of Kent, the Ignaz Semmelweis Institute, and Vetmeduni Vienna.
New study:
ColdZyme®
reduces cold duration and symptoms
A new scientific article published in the The Journal of Physiology, confirms that ColdZyme not only alleviates cold symptoms but can also reduce the number of sick days. The article is a collaboration between the University of Kent, the Ignaz Semmelweis Institute, and Vetmeduni Vienna.
The evidence behind ColdZyme®
The latest independent study shows that ColdZyme shortens illness duration, alleviates symptoms, and reduces viral loads in upper respiratory tract infections. ColdZyme addresses the underlying cause of upper respiratory infections by physically inhibiting the virus's spread and protecting the cells in the airways. The results reinforce ColdZyme’s position as an effective support for fighting the cause of colds, both for athletes and the general public.
Key results from the study
-
-
Reduced viral load:
Rhinovirus levels were significantly reduced in both studies on athletes and cell models.
-
Protected cells:
Infected cells were nearly restored to their normal condition.
The evidence behind ColdZyme®
The latest independent study shows that ColdZyme shortens illness duration, alleviates symptoms, and reduces viral loads in upper respiratory tract infections. ColdZyme addresses the underlying cause of upper respiratory infections by physically inhibiting the virus's spread and protecting the cells in the airways. The results reinforce ColdZyme’s position as an effective support for fighting the cause of colds, both for athletes and the general public.
Key results from the study
-
Shorter illness duration:
ColdZyme reduced the duration of upper respiratory tract infections.
-
Reduced viral load:
Rhinovirus levels were significantly reduced in both studies on athletes and cell models.
-
Protected cells:
Infected cells were nearly restored to their normal condition.
HOW COLDZYME® WORKS
At the first signs of a cold, spray ColdZyme into the back of your throat. ColdZyme immediately creates a barrier that captures the viruses that are causing the symptoms and subsequently inhibits their ability to infect other cells and replicate.
Triple acting effect
Shortens
Shortens the duration of cold symptoms when used early during an infection.
Relieves
Relieves common cold symptoms, such as sore throat.
Protects
Use to protect when in areas with potential exposure to cold viruses
Listen to the science
Meet professors Glen Davison and Doris Wilflingseder – the researchers behind the studies confirming ColdZyme’s effectiveness. In the films, they share insights into the science, the results, and why ColdZyme makes a difference.
Press kit
Here you can find the study, product images, logos, and other relevant material.
"After treatment with ColdZyme®, previously infected cells appeared almost healthy, with intact nuclei and minimal damage from the virus."
"ColdZyme® can reduce the number of sick days and improve quality of life, both for athletes and working professionals."
What are the benefits of ColdZyme for athletes?
Charlotte Hodgkins-Byrne, international rower and Enzymatica’s Director of Strategic Partnerships, is here to help. Get in touch to learn more about how ColdZyme can support athletic performance and recovery.
